Connor, Clark & Lunn Investment Management (CC&L)’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.3M | Sell |
|
|||||
|
2025
Q1 | $85.8M | Sell |
|
|||||
|
2024
Q4 | $40.2M | Sell |
|
|||||
|
2024
Q3 | $39.8M | Buy |
|
|||||
|
2024
Q2 | $23.3M | Buy |
|
|||||
|
2024
Q1 | $13.7M | Buy |
|
|||||
|
2023
Q4 | $11.7M | Sell |
|
|||||
|
2023
Q3 | $9.87M | Sell |
|
|||||
|
2023
Q2 | $8.07M | Buy |
|
|||||
|
2023
Q1 | $4.79M | Buy |
|
|||||
|
2022
Q4 | $2.82M | Buy |
|
|||||
|
2022
Q3 | $2.11M | Buy |
|
|||||
|
2022
Q2 | $1.78M | Sell |
|
|||||
|
2022
Q1 | $3.1M | Buy |
|
|||||
|
2021
Q4 | $952K | Buy |
|
|||||
|
2021
Q3 | $233K | Buy |
|